Kaiser Permanente Bellflower Medical Offices — Bellflower, California

Kaiser Permanente Bellflower Medical Offices is a clinical research site located in Bellflower, California, United States 90706.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Kaiser Permanente Bellflower Medical Offices has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies.

Sponsors: Ariad Pharmaceuticals, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bellflower

Browse all research sites in California · View every site in Bellflower

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente Bellflower Medical Offices?

Kaiser Permanente Bellflower Medical Offices has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente Bellflower Medical Offices conducted?

Kaiser Permanente Bellflower Medical Offices has 3 clinical trials on record, with 2 currently active. Their work covers Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies.

Is Kaiser Permanente Bellflower Medical Offices accredited by Crixeo Clinical Trials?

Kaiser Permanente Bellflower Medical Offices has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente Bellflower Medical Offices?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.